Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>Macquarie Chops CONANT OPTICAL (02276.HK) TP to $88, Keeps Outperform Rating
Recommend 2 Positive 2 Negative 1 |
||||
|
||||
|
CONANT OPTICAL (02276.HK) recently signed a memorandum of understanding (MOU) with a globally leading smart glasses technology company to manufacture its next-generation smart glasses, Macquarie published a research report saying. The broker believed that this marks an important milestone for CONANT OPTICAL, given its leadership in ultra-thin lens technology for display-type glasses and its global certifications (FDA, CE, ISO). It is also one of the few prescription lens manufacturers worldwide capable of co-developing next-generation smart glasses with tech giants. Macquarie lowered its 2026-2027 EPS forecasts for CONANT OPTICAL by 20%/ 8% each to reflect reduced revenue projections for its AI glasses business and an adjustment in the number of shares. However, the broker kept rating at Outperform, and chopped its target price from $95.6 to $88, based on an unchanged projected 2027 PE ratio of 30x. Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
